195 related articles for article (PubMed ID: 15481152)
1. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2.
Kanazawa N; Tashiro K; Miyachi Y
Immunobiology; 2004; 209(1-2):179-90. PubMed ID: 15481152
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells.
Kanazawa N
J Dermatol Sci; 2007 Feb; 45(2):77-86. PubMed ID: 17046204
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell inhibitory and activating immunoreceptors (DCIR and DCAR) in duck: Genomic organization and expression.
Guo X; Branton WG; Moon DA; Xia J; Macdonald MR; Magor KE
Mol Immunol; 2008 Sep; 45(15):3942-6. PubMed ID: 18657864
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with Fc receptor gamma chain.
Kanazawa N; Tashiro K; Inaba K; Miyachi Y
J Biol Chem; 2003 Aug; 278(35):32645-52. PubMed ID: 12777403
[TBL] [Abstract][Full Text] [Related]
5. DCIR interacts with ligands from both endogenous and pathogenic origin.
Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
[TBL] [Abstract][Full Text] [Related]
6. Enhanced dendritic cell-induced immune responses mediated by the novel C-type lectin receptor mDCAR1.
Kaden SA; Kurig S; Vasters K; Hofmann K; Zaenker KS; Schmitz J; Winkels G
J Immunol; 2009 Oct; 183(8):5069-78. PubMed ID: 19786536
[TBL] [Abstract][Full Text] [Related]
7. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif.
Bates EE; Fournier N; Garcia E; Valladeau J; Durand I; Pin JJ; Zurawski SM; Patel S; Abrams JS; Lebecque S; Garrone P; Saeland S
J Immunol; 1999 Aug; 163(4):1973-83. PubMed ID: 10438934
[TBL] [Abstract][Full Text] [Related]
8. The Dectin-2 family of C-type lectins in immunity and homeostasis.
Graham LM; Brown GD
Cytokine; 2009; 48(1-2):148-55. PubMed ID: 19665392
[TBL] [Abstract][Full Text] [Related]
9. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.
Klechevsky E; Flamar AL; Cao Y; Blanck JP; Liu M; O'Bar A; Agouna-Deciat O; Klucar P; Thompson-Snipes L; Zurawski S; Reiter Y; Palucka AK; Zurawski G; Banchereau J
Blood; 2010 Sep; 116(10):1685-97. PubMed ID: 20530286
[TBL] [Abstract][Full Text] [Related]
10. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.
Meyer-Wentrup F; Benitez-Ribas D; Tacken PJ; Punt CJ; Figdor CG; de Vries IJ; Adema GJ
Blood; 2008 Apr; 111(8):4245-53. PubMed ID: 18258799
[TBL] [Abstract][Full Text] [Related]
11. Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain.
Bloem K; Vuist IM; van der Plas AJ; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
PLoS One; 2013; 8(6):e66266. PubMed ID: 23776650
[TBL] [Abstract][Full Text] [Related]
12. DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif.
Kanazawa N; Okazaki T; Nishimura H; Tashiro K; Inaba K; Miyachi Y
J Invest Dermatol; 2002 Feb; 118(2):261-6. PubMed ID: 11841542
[TBL] [Abstract][Full Text] [Related]
13. Cellular distribution of the C-type II lectin dendritic cell immunoreceptor (DCIR) and its expression in the rheumatic joint: identification of a subpopulation of DCIR+ T cells.
Eklöw C; Makrygiannakis D; Bäckdahl L; Padyukov L; Ulfgren AK; Lorentzen JC; Malmström V
Ann Rheum Dis; 2008 Dec; 67(12):1742-9. PubMed ID: 18250113
[TBL] [Abstract][Full Text] [Related]
14. DCIR negatively regulates CpG-ODN-induced IL-1β and IL-6 production.
Zhao X; Shen Y; Hu W; Chen J; Wu T; Sun X; Yu J; Wu T; Chen W
Mol Immunol; 2015 Dec; 68(2 Pt C):641-7. PubMed ID: 26514427
[TBL] [Abstract][Full Text] [Related]
15. The Dectin-2 family of C-type lectin-like receptors: an update.
Kerscher B; Willment JA; Brown GD
Int Immunol; 2013 May; 25(5):271-7. PubMed ID: 23606632
[TBL] [Abstract][Full Text] [Related]
16. DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production.
Meyer-Wentrup F; Cambi A; Joosten B; Looman MW; de Vries IJ; Figdor CG; Adema GJ
J Leukoc Biol; 2009 Mar; 85(3):518-25. PubMed ID: 19028959
[TBL] [Abstract][Full Text] [Related]
17. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells.
Florentin J; Aouar B; Dental C; Thumann C; Firaguay G; Gondois-Rey F; Soumelis V; Baumert TF; Nunès JA; Olive D; Hirsch I; Stranska R
Blood; 2012 Nov; 120(23):4544-51. PubMed ID: 23053572
[TBL] [Abstract][Full Text] [Related]
18. From structure to function - Ligand recognition by myeloid C-type lectin receptors.
Fischer S; Stegmann F; Gnanapragassam VS; Lepenies B
Comput Struct Biotechnol J; 2022; 20():5790-5812. PubMed ID: 36382179
[TBL] [Abstract][Full Text] [Related]
19. DC-SIGN plays a stronger role than DCIR in mediating HIV-1 capture and transfer.
Jin W; Li C; Du T; Hu K; Huang X; Hu Q
Virology; 2014 Jun; 458-459():83-92. PubMed ID: 24928041
[TBL] [Abstract][Full Text] [Related]
20. DCIR and its ligand asialo-biantennary N-glycan regulate DC function and osteoclastogenesis.
Kaifu T; Yabe R; Maruhashi T; Chung SH; Tateno H; Fujikado N; Hirabayashi J; Iwakura Y
J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34817551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
